|
|
 |
Products on the Pipeline
There is a growing pipeline of RescuDerm™ products that address specific areas of skin injury. Our current research continues to uncover unsuspected roles of nociceptors in such injuries, which can be successfully, and immediately targeted by our technology. Contingent on patent filings, regulatory issues and confirmatory research results, nine new products have now been identified and are in various stages of development, expected to be delivered to our marketing division over the next two to three years, preceding the launching of prescription drugs now under long-range development. The discovery of extremely rapid, broad-spectrum effective antimicrobial effects in a our K2 gel, a cousin to RescuDerm™, opens new applications in medical, veterinary and food safety markets.
|
|
|
|
